Annual CFI
$68.98 M
+$34.54 M+100.29%
31 December 2023
Summary:
Eliem Therapeutics annual cash flow from investing activities is currently $68.98 million, with the most recent change of +$34.54 million (+100.29%) on 31 December 2023. During the last 3 years, it has risen by +$60.90 million (+753.94%). ELYM annual CFI is now at all-time high.ELYM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$71.79 M
-$62.14 M-644.31%
30 September 2024
Summary:
Eliem Therapeutics quarterly cash flow from investing activities is currently -$71.79 million, with the most recent change of -$62.14 million (-644.31%) on 30 September 2024. Over the past year, it has dropped by -$99.83 million (-356.05%). ELYM quarterly CFI is now -295.35% below its all-time high of $36.75 million, reached on 31 December 2023.ELYM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$30.93 M
-$99.83 M-144.90%
30 September 2024
Summary:
Eliem Therapeutics TTM cash flow from investing activities is currently -$30.93 million, with the most recent change of -$99.83 million (-144.90%) on 30 September 2024. Over the past year, it has dropped by -$77.45 million (-166.51%). ELYM TTM CFI is now -140.21% below its all-time high of $76.94 million, reached on 31 March 2024.ELYM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.3% | -356.1% | -166.5% |
| 3 y3 years | +753.9% | +32.9% | +68.7% |
| 5 y5 years | - | - | - |
ELYM Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +160.0% | -295.4% | +32.9% | -140.2% | +74.0% |
| 5 y | 5 years | at high | +160.0% | -295.4% | +32.9% | -140.2% | +74.0% |
| alltime | all time | at high | +160.0% | -295.4% | +32.9% | -140.2% | +74.0% |
Eliem Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$71.79 M(+644.3%) | -$30.93 M(-144.9%) |
| June 2024 | - | -$9.64 M(-170.1%) | $68.89 M(-10.5%) |
| Mar 2024 | - | $13.75 M(-62.6%) | $76.94 M(+11.5%) |
| Dec 2023 | $68.98 M(+100.3%) | $36.75 M(+31.1%) | $68.98 M(+48.3%) |
| Sept 2023 | - | $28.04 M(-1851.2%) | $46.51 M(+72.4%) |
| June 2023 | - | -$1.60 M(-127.6%) | $26.98 M(-39.1%) |
| Mar 2023 | - | $5.80 M(-59.4%) | $44.27 M(+28.5%) |
| Dec 2022 | $34.44 M | $14.28 M(+67.8%) | $34.44 M(+184.4%) |
| Sept 2022 | - | $8.51 M(-45.8%) | $12.11 M(-111.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $15.69 M(-488.8%) | -$103.32 M(-13.2%) |
| Mar 2022 | - | -$4.04 M(-49.9%) | -$119.00 M(+3.5%) |
| Dec 2021 | -$114.97 M(-1523.2%) | -$8.05 M(-92.5%) | -$114.97 M(+16.3%) |
| Sept 2021 | - | -$106.92 M(<-9900.0%) | -$98.84 M(-1323.6%) |
| June 2021 | - | $0.00(0.0%) | $8.08 M(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) | $8.08 M(0.0%) |
| Dec 2020 | $8.08 M(>+9900.0%) | $8.08 M(>+9900.0%) | $8.08 M(>+9900.0%) |
| Sept 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Eliem Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Eliem Therapeutics?
- What is Eliem Therapeutics annual CFI year-on-year change?
- What is Eliem Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly CFI year-on-year change?
- What is Eliem Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Eliem Therapeutics?
- What is Eliem Therapeutics TTM CFI year-on-year change?
What is Eliem Therapeutics annual cash flow from investing activities?
The current annual CFI of ELYM is $68.98 M
What is the all time high annual CFI for Eliem Therapeutics?
Eliem Therapeutics all-time high annual cash flow from investing activities is $68.98 M
What is Eliem Therapeutics annual CFI year-on-year change?
Over the past year, ELYM annual cash flow from investing activities has changed by +$34.54 M (+100.29%)
What is Eliem Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ELYM is -$71.79 M
What is the all time high quarterly CFI for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly cash flow from investing activities is $36.75 M
What is Eliem Therapeutics quarterly CFI year-on-year change?
Over the past year, ELYM quarterly cash flow from investing activities has changed by -$99.83 M (-356.05%)
What is Eliem Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ELYM is -$30.93 M
What is the all time high TTM CFI for Eliem Therapeutics?
Eliem Therapeutics all-time high TTM cash flow from investing activities is $76.94 M
What is Eliem Therapeutics TTM CFI year-on-year change?
Over the past year, ELYM TTM cash flow from investing activities has changed by -$77.45 M (-166.51%)